ArticleJournal of the American Heart Association2019

Rivaroxaban, a Direct Factor Xa Inhibitor, Ameliorates Hypertensive Renal Damage Through Inhibition of the Inflammatory Response Mediated by Protease-Activated Receptor Pathway.

Hiroaki Ichikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.